WEED, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Glenn E. Martin
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 4920 North Post Trail Tucson AZ United States of America 85750
- IPO Date
- Apr 5, 2010
- CIK
- 0001393772
- Website
- weedincusa.com
- Similar Companies
- Business
- WEED, Inc. (OTCQB: BUDZ) operates as a holding company focused on the development and application of cannabis-derived and hemp-derived compounds for the treatment of human diseases and animal ailments; it engages in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry through subsidiaries such as Sangre BioSciences and HEMP BioSciences Inc.; and it pursues cultivation, research, product development, processing, and manufacturing of pharma and non-pharma cannabis and hemp products, including strain-specific therapies and consumer packaged goods utilizing rare Landrace strains like Original Panama Red, Acapulco Gold, Red Bud Colombian, Santa Marta Gold, African Ebony, Jamaican, Thai, and Andalusian Nepalese. The company holds five HEMP licenses in Arizona and explores THC grow licensing opportunities; it maintains operations in the United States and Australia, with subsidiaries including WEED Australia Ltd., WEED Israel Cannabis Ltd., and previously WEED Hong Kong Limited; and it targets medical cannabis, hemp bioresearch, and global markets for therapeutics, treatments, and branded products in cosmetics, natural agricultural goods, edibles, and beverages. Founded in 1999 and headquartered in Tucson, Arizona, WEED, Inc. was formerly United Mines, Inc., changing its name in February 2015. Recent developments include the acquisition of Hempirical Genetics, LLC in exchange for 2 million shares and $250,000 cash, adding over 30 new CBD and CBG strains for product development and clinical trials; securing trademark registrations for Panama Red and WEED in the USA and Canada; deregistration of Cannabis Institute of Australia and WEED Hong Kong for cost reduction; attendance at the Pharmaceutical Guild of Australia conference; release of 2024 highlights announcing 2025 expansion into consumer packaged goods; and maintenance of no long-term debt with approximately 125 million shares outstanding.
WEED, Inc. (OTCQB:BUDZ) Unveils 2026 Growth Vision Combining Cannabis Operations, Proprietary Genetics, and Digital Asset Innovation
WEED Inc. Engages Advisors to Evaluate Strategic Alternatives for Sugar Hill Asset and Broader Corporate Platform
WEED Inc (OTCQB:BUDZ) Looks to Advance a High-Value AI Data Center Opportunity for The Four Winds of Lake Erie, LLC. On Our Prime Lake Erie Waterfront Property
WEED Inc. Forms Strategic Partnership with Remergify Inc. to Design, Develop, Program, Deploy & Coordinate the Launch of WEEDCoin & BUDZCoin in the AI/Crypto/Blockchain Universe
WEED: Concentrated, Swap-Heavy, And Too Illiquid For Comfort
WEED Inc. President and CEO Releases Letter to Shareholders
HEMP BioSciences Inc. a Wholly-owned Division of WEED Inc. Receives Full Suite of Industrial Hemp Licenses From State of Arizona
WEED Inc Announces Exit from Colorado Cannabis Marketplace with Sale of Sangre Biosciences 4-Acre Campus & Hilltop Headquarters for $3.1 million
WEED Australia Ltd is Proud to Announce the Appointment of Ms. Amanda Brunskill-Scott and Mrs.
MMJ Group makes C$1 million follow-on investment in Weed Me Inc in preparation for liquidity event